Pathology Grand Rounds - Nuances and Pitfalls in Evaluating Treated IDH-Mutant Gliomas

At the conclusion of this activity, learners should be able to: * Describe the natural history of IDH-mutant gliomas following standard therapies * Explain the potential utility in resampling IDH-mutant gliomas after treatment * Build a differential diagnosis when a supposed post-treatment IDH-mutant glioma specimen lacks a detectable IDH mutation